Exelixis (EXEL) Receivables - Other (2010 - 2021)
Exelixis' (EXEL) quarterly Receivables - Other came in at $9.7 million in Q3 2021, down 29.36% year-on-year from $13.8 million in Q3 2020, and down 29.36% quarter-over-quarter from $13.8 million in Q3 2020.
Exelixis (EXEL) Receivables - Other (2010 - 2021) Analysis & Trends
Exelixis' Receivables - Other history runs 10 years deep, the most recent figure standing at $9.7 million for Q3 2021.
- On a quarterly basis, Receivables - Other fell 29.36% year-over-year to $9.7 million in Q3 2021; TTM through Jul 2021 was $9.7 million, a 29.36% decrease from a year earlier, with the FY2020 full-year figure at $1.1 million, down 75.92% from the prior year.
- Receivables - Other declined to $9.7 million in Q3 2021 per EXEL's latest filing, from $13.8 million in the prior quarter.
- Across five years, Receivables - Other topped out at $31.8 million in Q1 2018 and bottomed at -$8.7 million in Q1 2019.
- The 5-year median for Receivables - Other is $11.1 million (2019), against an average of $10.4 million.
- Across the five-year window, Receivables - Other sank 127.45% in 2019 and grew 11.38% in 2020, its largest moves.
- Year by year, Receivables - Other stood at $3.9 million in 2017, then slumped by 62.18% to $1.5 million in 2018, then surged by 837.57% to $13.8 million in 2019, then dropped by 0.01% to $13.8 million in 2020, then declined by 29.36% to $9.7 million in 2021.
- Per Business Quant, the three latest EXEL Receivables - Other figures stand at $9.7 million (Q3 2021), $13.8 million (Q3 2020), and $1.1 million (Q1 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 2, 2021 | 9.75 Mn |
| Jul 2, 2021 | 9.75 Mn |
| Jul 3, 2020 | 13.80 Mn |
| Jul 3, 2020 | 13.80 Mn |
| Jan 3, 2020 | 1.06 Mn |
| Jan 3, 2020 | 1.06 Mn |
| Sep 27, 2019 | 13.80 Mn |
| Sep 27, 2019 | 13.80 Mn |
| Jun 28, 2019 | 12.39 Mn |
| Jun 28, 2019 | 12.39 Mn |
| Mar 29, 2019 | -8.74 Mn |
| Mar 29, 2019 | -8.74 Mn |
| Dec 28, 2018 | 1.47 Mn |
| Dec 28, 2018 | 1.47 Mn |
| Sep 28, 2018 | 24.49 Mn |
| Sep 28, 2018 | 24.49 Mn |
| Mar 30, 2018 | 31.84 Mn |
| Mar 30, 2018 | 31.84 Mn |
| Dec 29, 2017 | 3.89 Mn |
| Dec 29, 2017 | 3.89 Mn |